China Pharma Holdings, Inc.CPHINYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank79
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Latest
2.99%
↑ 145% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-6.70%
Historical baseline
PeriodValue
20242.99%
2023-24.19%
2022-5.82%
2021-22.09%
2020-13.01%
2019-10.15%
2018-5.73%
2017-13.04%
20161.80%
201522.28%